Candriam SCA’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
|
|||||
|
2025
Q1 | $13M | Buy |
|
|||||
|
2024
Q4 | $10.5M | Buy |
|
|||||
|
2024
Q3 | $14.9M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.63M | Buy |
|
|||||
|
2023
Q3 | $1.09M | Hold |
|
|||||
|
2023
Q2 | $1.89M | Hold |
|
|||||
|
2023
Q1 | $2.4M | Sell |
|
|||||
|
2022
Q4 | $4.68M | Hold |
|
|||||
|
2022
Q3 | $3.45M | Hold |
|
|||||
|
2022
Q2 | $3.07M | Buy |
|
|||||
|
2022
Q1 | $2.96M | Hold |
|
|||||
|
2021
Q4 | $3.8M | Buy |
|
|||||
|
2021
Q3 | $3.91M | Sell |
|
|||||
|
2021
Q2 | $3.95M | Buy |
|
|||||
|
2021
Q1 | $478K | Hold |
|
|||||
|
2020
Q4 | $498K | Sell |
|
|||||
|
2020
Q3 | $563K | Hold |
|
|||||
|
2020
Q2 | $565K | Buy |
|